vs
Assertio Holdings, Inc.（ASRT）与INTERGROUP CORP（INTG）财务数据对比。点击上方公司名可切换其他公司
INTERGROUP CORP的季度营收约是Assertio Holdings, Inc.的1.3倍（$17.3M vs $13.5M），INTERGROUP CORP同比增速更快（19.8% vs -57.9%），过去两年INTERGROUP CORP的营收复合增速更高（7.8% vs -35.4%）
Assertio Therapeutics是一家美国专业制药企业，主要聚焦神经病学、疼痛以及中枢神经系统疾病领域的产品销售与推广。公司前身Depomed成立于1995年，总部位于加利福尼亚州纽瓦克，拥有多款获美国FDA批准的产品，目前在纳斯达克上市。
Intergroup Corp是一家多元化控股企业，核心业务覆盖房地产与酒店运营两大板块。公司在美国境内持有、管理及租赁商住类物业，同时运营面向休闲和商务旅客的有限服务型酒店。
ASRT vs INTG — 直观对比
营收规模更大
INTG
是对方的1.3倍
$13.5M
营收增速更快
INTG
高出77.7%
-57.9%
两年增速更快
INTG
近两年复合增速
-35.4%
损益表 — Q4 FY2025 vs Q2 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $13.5M | $17.3M |
| 净利润 | — | $1.5M |
| 毛利率 | — | — |
| 营业利润率 | -86.7% | 11.6% |
| 净利率 | — | 8.8% |
| 营收同比 | -57.9% | 19.8% |
| 净利润同比 | — | 155.6% |
| 每股收益（稀释后） | $-4.54 | $0.71 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASRTINTG
| Q4 25 | $13.5M | $17.3M | ||
| Q3 25 | $49.5M | $17.9M | ||
| Q2 25 | $29.2M | $16.2M | ||
| Q1 25 | $26.5M | $16.8M | ||
| Q4 24 | $32.2M | $14.4M | ||
| Q3 24 | $29.2M | $16.9M | ||
| Q2 24 | $31.1M | $13.4M | ||
| Q1 24 | $32.4M | $14.9M |
净利润ASRTINTG
| Q4 25 | — | $1.5M | ||
| Q3 25 | $11.4M | $-535.0K | ||
| Q2 25 | $-16.4M | $-2.2M | ||
| Q1 25 | $-13.5M | $-578.0K | ||
| Q4 24 | — | $-2.7M | ||
| Q3 24 | $-2.9M | $-398.0K | ||
| Q2 24 | $-3.7M | $-4.9M | ||
| Q1 24 | $-4.5M | $-3.2M |
营业利润率ASRTINTG
| Q4 25 | -86.7% | 11.6% | ||
| Q3 25 | 23.2% | 15.3% | ||
| Q2 25 | -27.5% | 8.1% | ||
| Q1 25 | -50.0% | 14.0% | ||
| Q4 24 | -41.9% | 5.9% | ||
| Q3 24 | -10.4% | 18.5% | ||
| Q2 24 | -11.6% | 3.7% | ||
| Q1 24 | -13.4% | 4.8% |
净利率ASRTINTG
| Q4 25 | — | 8.8% | ||
| Q3 25 | 23.1% | -3.0% | ||
| Q2 25 | -56.0% | -13.9% | ||
| Q1 25 | -51.1% | -3.4% | ||
| Q4 24 | — | -18.9% | ||
| Q3 24 | -10.0% | -2.4% | ||
| Q2 24 | -11.8% | -36.7% | ||
| Q1 24 | -13.9% | -21.3% |
每股收益（稀释后）ASRTINTG
| Q4 25 | $-4.54 | $0.71 | ||
| Q3 25 | $0.11 | $-0.25 | ||
| Q2 25 | $-0.17 | — | ||
| Q1 25 | $-0.14 | $-0.27 | ||
| Q4 24 | $-3.28 | $-1.26 | ||
| Q3 24 | $-0.03 | $-0.18 | ||
| Q2 24 | $-0.04 | — | ||
| Q1 24 | $-0.05 | $-1.44 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $63.4M | $7.5M |
| 总债务越低越好 | — | $233.2M |
| 股东权益账面价值 | $94.0M | $-85.2M |
| 总资产 | $267.0M | $101.1M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ASRTINTG
| Q4 25 | $63.4M | $7.5M | ||
| Q3 25 | $93.4M | $6.0M | ||
| Q2 25 | $98.2M | $6.1M | ||
| Q1 25 | $87.3M | $4.8M | ||
| Q4 24 | $100.1M | $15.4M | ||
| Q3 24 | $88.6M | $12.2M | ||
| Q2 24 | $88.4M | $11.6M | ||
| Q1 24 | $80.7M | $19.5M |
总债务ASRTINTG
| Q4 25 | — | $233.2M | ||
| Q3 25 | — | $237.8M | ||
| Q2 25 | — | $240.5M | ||
| Q1 25 | — | $241.5M | ||
| Q4 24 | — | $227.2M | ||
| Q3 24 | — | $218.1M | ||
| Q2 24 | — | $225.7M | ||
| Q1 24 | $38.6M | $225.0M |
股东权益ASRTINTG
| Q4 25 | $94.0M | $-85.2M | ||
| Q3 25 | $105.8M | $-86.7M | ||
| Q2 25 | $93.3M | $-86.1M | ||
| Q1 25 | $108.5M | $-84.5M | ||
| Q4 24 | $121.1M | $-83.9M | ||
| Q3 24 | $130.5M | $-80.9M | ||
| Q2 24 | $132.2M | $-80.3M | ||
| Q1 24 | $134.5M | $-76.4M |
总资产ASRTINTG
| Q4 25 | $267.0M | $101.1M | ||
| Q3 25 | $319.8M | $102.5M | ||
| Q2 25 | $273.8M | $104.1M | ||
| Q1 25 | $286.4M | $103.2M | ||
| Q4 24 | $284.7M | $110.6M | ||
| Q3 24 | $276.0M | $109.3M | ||
| Q2 24 | $279.4M | $107.8M | ||
| Q1 24 | $282.0M | $119.0M |
负债/权益比ASRTINTG
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.29× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-30.0M | $-23.0K |
| 自由现金流经营现金流 - 资本支出 | — | $-481.0K |
| 自由现金流率自由现金流/营收 | — | -2.8% |
| 资本支出强度资本支出/营收 | — | 2.6% |
| 现金转化率经营现金流/净利润 | — | -0.02× |
| 过去12个月自由现金流最近4个季度 | — | $739.0K |
8季度趋势，按日历期对齐
经营现金流ASRTINTG
| Q4 25 | $-30.0M | $-23.0K | ||
| Q3 25 | $-4.8M | $-296.0K | ||
| Q2 25 | $19.1M | $5.9M | ||
| Q1 25 | $-12.5M | $-854.0K | ||
| Q4 24 | $11.5M | $-781.0K | ||
| Q3 24 | $-35.0K | $3.4M | ||
| Q2 24 | $7.4M | $6.8M | ||
| Q1 24 | $7.5M | $1.9M |
自由现金流ASRTINTG
| Q4 25 | — | $-481.0K | ||
| Q3 25 | — | $-1.3M | ||
| Q2 25 | — | $3.6M | ||
| Q1 25 | — | $-1.2M | ||
| Q4 24 | — | $-1.1M | ||
| Q3 24 | — | $3.1M | ||
| Q2 24 | — | $2.7M | ||
| Q1 24 | — | $1.1M |
自由现金流率ASRTINTG
| Q4 25 | — | -2.8% | ||
| Q3 25 | — | -7.1% | ||
| Q2 25 | — | 22.5% | ||
| Q1 25 | — | -6.8% | ||
| Q4 24 | — | -7.8% | ||
| Q3 24 | — | 18.3% | ||
| Q2 24 | — | 20.4% | ||
| Q1 24 | — | 7.6% |
资本支出强度ASRTINTG
| Q4 25 | — | 2.6% | ||
| Q3 25 | — | 5.4% | ||
| Q2 25 | — | 13.9% | ||
| Q1 25 | — | 1.8% | ||
| Q4 24 | — | 2.4% | ||
| Q3 24 | 0.0% | 1.6% | ||
| Q2 24 | — | 30.4% | ||
| Q1 24 | — | 4.9% |
现金转化率ASRTINTG
| Q4 25 | — | -0.02× | ||
| Q3 25 | -0.42× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASRT
| Products | $12.8M | 95% |
| Other | $719.0K | 5% |
INTG
| Hotel Operations | $12.7M | 73% |
| Real Estate Operation | $4.6M | 27% |
